Meridian Diagnostics
This article was originally published in The Gray Sheet
Executive Summary
Expands line of enzyme immunoassay and fluorescent antibody offerings with purchase of Johnson & Johnson infectious disease products. In exchange for $3.3 mil. cash "plus inventory and additional future royalty payments," Meridian is gaining products to aid in the diagnosis of "certain viral diseases such as herpes, respiratory syncytial virus, chicken pox and certain serious bacterial infections such as chlamydia," a Jan. 26 release states. Annual sales from the line amount to about $5 mil. Under the terms of the deal, Meridian also "will manufacture certain products" for J&J's Ortho Diagnostic Systems